Subcutaneous apomorphine and the nonmotor features of Parkinson’s disease
- 31 October 2026
- journal article
- review article
- Published by Springer Nature in Journal of Neural Transmission
- p. 1-21
Abstract
No abstract availableKeywords
This publication has 248 references indexed in Scilit:
- Beyond the Dopaminergic System: Lessons Learned from levodopa Resistant Symptoms in Parkinson's DiseaseMovement Disorders Clinical Practice, 2023
- Continuous Subcutaneous Apomorphine Infusion before Subthalamic Deep Brain Stimulation: A Prospective, Comparative Study in 20 PatientsMovement Disorders Clinical Practice, 2021
- Randomized Controlled Trials Versus Real World Evidence: Neither Magic Nor MythClinical Pharmacology & Therapeutics, 2020
- Dopamine-Mediated Yawning-Fatigue Syndrome With Specific Recurrent Initiation and Responsiveness to OpioidsJAMA Neurology, 2020
- Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson DiseaseJAMA Neurology, 2019
- Apomorphine‐Induced Immune Hemolytic AnemiaMovement Disorders Clinical Practice, 2016
- Apomorphine Therapy: The Hazard of Left Over NeedlesMovement Disorders Clinical Practice, 2015
- Reports of Pathological Gambling, Hypersexuality, and Compulsive Shopping Associated With Dopamine Receptor Agonist DrugsJAMA Internal Medicine, 2014
- Evidence-Based MedicineJAMA, 1992
- Anal Sphincter Dysfunction in Parkinson's DiseaseArchives of Neurology, 1989